310 related articles for article (PubMed ID: 33137363)
1. Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic.
Lam JKW; Cheung CCK; Chow MYT; Harrop E; Lapwood S; Barclay SIG; Wong ICK
Adv Drug Deliv Rev; 2020; 160():234-243. PubMed ID: 33137363
[TBL] [Abstract][Full Text] [Related]
2. Anticipatory prescribing in community end-of-life care in the UK and Ireland during the COVID-19 pandemic: online survey.
Antunes B; Bowers B; Winterburn I; Kelly MP; Brodrick R; Pollock K; Majumder M; Spathis A; Lawrie I; George R; Ryan R; Barclay S
BMJ Support Palliat Care; 2020 Sep; 10(3):343-349. PubMed ID: 32546559
[TBL] [Abstract][Full Text] [Related]
3. Orodispersible and transmucosal alternative medications for symptom control in adults.
Sutherland AE; Presland M; Harrop E; Carey M; Miller M; Wong ICKC
BMJ Support Palliat Care; 2022 Sep; 12(3):305-315. PubMed ID: 33262121
[TBL] [Abstract][Full Text] [Related]
4. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications.
Zhang H; Zhang J; Streisand JB
Clin Pharmacokinet; 2002; 41(9):661-80. PubMed ID: 12126458
[TBL] [Abstract][Full Text] [Related]
5. Conservative Management of COVID-19 Patients-Emergency Palliative Care in Action.
Fusi-Schmidhauser T; Preston NJ; Keller N; Gamondi C
J Pain Symptom Manage; 2020 Jul; 60(1):e27-e30. PubMed ID: 32276101
[TBL] [Abstract][Full Text] [Related]
6. Integration of palliative care into COVID-19 pandemic planning.
Fadul N; Elsayem AF; Bruera E
BMJ Support Palliat Care; 2021 Mar; 11(1):40-44. PubMed ID: 32527790
[TBL] [Abstract][Full Text] [Related]
7. Alternative routes to oral opioid administration in palliative care: a review and clinical summary.
Kestenbaum MG; Vilches AO; Messersmith S; Connor SR; Fine PG; Murphy B; Davis M; Muir JC
Pain Med; 2014 Jul; 15(7):1129-53. PubMed ID: 24995406
[TBL] [Abstract][Full Text] [Related]
8. Oral transmucosal drug delivery for pediatric use.
Lam JK; Xu Y; Worsley A; Wong IC
Adv Drug Deliv Rev; 2014 Jun; 73():50-62. PubMed ID: 23999459
[TBL] [Abstract][Full Text] [Related]
9. Palatal mucosa as a route for systemic drug delivery: A review.
Shakya P; Madhav NV; Shakya AK; Singh K
J Control Release; 2011 Apr; 151(1):2-9. PubMed ID: 21059376
[TBL] [Abstract][Full Text] [Related]
10. Orotransmucosal drug delivery systems: a review.
Madhav NV; Shakya AK; Shakya P; Singh K
J Control Release; 2009 Nov; 140(1):2-11. PubMed ID: 19665039
[TBL] [Abstract][Full Text] [Related]
11. The role and response of primary healthcare services in the delivery of palliative care in epidemics and pandemics: A rapid review to inform practice and service delivery during the COVID-19 pandemic.
Mitchell S; Maynard V; Lyons V; Jones N; Gardiner C
Palliat Med; 2020 Oct; 34(9):1182-1192. PubMed ID: 32736494
[TBL] [Abstract][Full Text] [Related]
12. Mucosal drug delivery: membranes, methodologies, and applications.
Song Y; Wang Y; Thakur R; Meidan VM; Michniak B
Crit Rev Ther Drug Carrier Syst; 2004; 21(3):195-256. PubMed ID: 15248809
[TBL] [Abstract][Full Text] [Related]
13. Innovation in a Crisis: Lessons Learned from the Rapid Development of an End-of-Life Palliative Care Unit during the COVID-19 Pandemic.
Drutchas A; Kavanaugh A; Cina K; Rinehart T; Krakauer EL; Doyle K; Davila C; Byrne-Martelli S; Kamdar M
J Palliat Med; 2021 Sep; 24(9):1280-1283. PubMed ID: 34096800
[TBL] [Abstract][Full Text] [Related]
14. Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
Sudhakar Y; Kuotsu K; Bandyopadhyay AK
J Control Release; 2006 Aug; 114(1):15-40. PubMed ID: 16828915
[TBL] [Abstract][Full Text] [Related]
15. Symptom management and end-of-life care of residents with COVID-19 in long-term care homes.
Khosravani H; Steinberg L; Incardona N; Quail P; Perri GA
Can Fam Physician; 2020 Jun; 66(6):404-406. PubMed ID: 32532719
[No Abstract] [Full Text] [Related]
16. Novel delivery systems: oral transmucosal and intranasal transmucosal.
Stanley TH; Ashburn MA
J Pain Symptom Manage; 1992 Apr; 7(3):163-71. PubMed ID: 16967585
[TBL] [Abstract][Full Text] [Related]
17. Novel instantly-soluble transmucosal matrix (ISTM) using dual mechanism solubilizer for sublingual and nasal delivery of dapoxetine hydrochloride: In-vitro/in-vivo evaluation.
Fouad SA; Shamma RN; Basalious EB; El-Nabarawi MA; Tayel SA
Int J Pharm; 2016 May; 505(1-2):212-22. PubMed ID: 27063851
[TBL] [Abstract][Full Text] [Related]
18. A Cost and Quality Analysis of Utilizing a Rectal Catheter for Medication Administration in End-of-Life Symptom Management.
Latuga NM; Gordon M; Farwell P; Farrell MO
J Pain Palliat Care Pharmacother; 2018; 32(2-3):63-70. PubMed ID: 30596459
[TBL] [Abstract][Full Text] [Related]
19. Role and support needs of nurses in delivering palliative and end of life care.
Gardiner C; Bolton L
Nurs Stand; 2021 Nov; 36(11):61-65. PubMed ID: 34693669
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
